The Urgency of Care during the Covid-19 Pandemic - Learning as We Go.
作者信息
Rubin Eric J, Harrington David P, Hogan Joseph W, Gatsonis Constantine, Baden Lindsey R, Hamel Mary Beth
机构信息
From the Department of Biostatistics, Harvard T.H. Chan School of Public Health, and the Department of Data Sciences, Dana-Farber Cancer Institute - both in Boston (D.P.H.); and the Department of Biostatistics, Brown University School of Public Health, Providence, RI (J.W.H., C.G.).
出版信息
N Engl J Med. 2020 Jun 18;382(25):2461-2462. doi: 10.1056/NEJMe2015903. Epub 2020 May 7.
Abstract
摘要
相似文献
1
The Urgency of Care during the Covid-19 Pandemic - Learning as We Go.新冠疫情期间护理的紧迫性——边实践边学习
N Engl J Med. 2020 Jun 18;382(25):2461-2462. doi: 10.1056/NEJMe2015903. Epub 2020 May 7.
2
Hydroxychloroquine in the treatment of COVID-19: How to use it waiting for conclusive scientific evidence.羟氯喹治疗新型冠状病毒肺炎：在等待确凿科学证据期间如何使用
Med Clin (Barc). 2020 Aug 14;155(3):134-135. doi: 10.1016/j.medcli.2020.05.006. Epub 2020 May 16.
3
Chloroquine and hydroxychloroquine for the prevention and therapy of coronavirus disease 2019: new hopes and old cardiovascular concerns.氯喹和羟氯喹用于预防和治疗2019冠状病毒病：新希望与旧有的心血管问题
Kardiol Pol. 2020 Aug 25;78(7-8):811-817. doi: 10.33963/KP.15511. Epub 2020 Jul 14.
4
Hydroxychloroquine-induced erythema multiforme in a patient with COVID-19.新冠病毒病患者中羟氯喹诱发的多形红斑
Med Clin (Barc). 2020 Sep 11;155(5):231. doi: 10.1016/j.medcli.2020.05.004. Epub 2020 May 19.
5
Chloroquine and hydroxychloroquine in covid-19.氯喹和羟氯喹在2019冠状病毒病中的应用
BMJ. 2020 Apr 8;369:m1432. doi: 10.1136/bmj.m1432.
6
[Brug af hydroxychloroquin til COVID-19].[羟氯喹用于新型冠状病毒肺炎]
Ugeskr Laeger. 2020 May 11;182(20).
7
Repurposing antimalarials and other drugs for COVID-19.将抗疟药及其他药物重新用于治疗新冠肺炎。
Travel Med Infect Dis. 2020 Mar-Apr;34:101658. doi: 10.1016/j.tmaid.2020.101658. Epub 2020 Apr 2.
8
A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19.仓促下结论？有关羟氯喹治疗 COVID-19 的快速报告和结果传播及其后果。
Ann Intern Med. 2020 Jun 16;172(12):819-821. doi: 10.7326/M20-1223. Epub 2020 Mar 30.
9
Emerging preclinical evidence does not support broad use of hydroxychloroquine in COVID-19 patients.新出现的临床前证据不支持在新冠肺炎患者中广泛使用羟氯喹。
Nat Commun. 2020 Aug 26;11(1):4253. doi: 10.1038/s41467-020-17907-w.
10
Shining a light on the evidence for hydroxychloroquine in SARS-CoV-2.揭示羟氯喹在新型冠状病毒肺炎中的证据
Crit Care. 2020 Apr 28;24(1):182. doi: 10.1186/s13054-020-02894-7.
引用本文的文献
1
Systematic Search and Scoping Review of Physicians' Intolerance of Uncertainty and Medical Decision-Making Uncertainties During the COVID-19 Pandemic: A Summary of the Literature and Directions for Future Research.对 COVID-19 大流行期间医生对不确定性的容忍度和医疗决策不确定性的系统搜索和范围综述：文献综述及未来研究方向。
J Clin Psychol Med Settings. 2024 Jun;31(2):338-358. doi: 10.1007/s10880-023-09974-0. Epub 2023 Nov 6.
2
Design of VA CoronavirUs Research and Efficacy Studies-1 (VA CURES-1): A double-blind, randomized placebo-controlled trial of COVID-19 convalescent plasma in hospitalized patients with early respiratory compromise.退伍军人事务部冠状病毒研究与疗效研究-1（VA CURES-1）的设计：一项针对早期出现呼吸功能不全的住院COVID-19患者进行的双盲、随机、安慰剂对照试验，使用新冠康复者血浆。
Contemp Clin Trials Commun. 2023 Jul 17;35:101190. doi: 10.1016/j.conctc.2023.101190. eCollection 2023 Oct.
3
Healthcare worker burnout during the first COVID-19 lockdown in Italy: experiences from an intensive neurological rehabilitation unit.意大利首次 COVID-19 封锁期间医护人员的倦怠：来自重症神经康复病房的经验。
J Int Med Res. 2023 Jul;51(7):3000605231182664. doi: 10.1177/03000605231182664.
4
Unit information prior for incorporating real-world evidence into randomized controlled trials.纳入真实世界证据的单位信息。
Stat Methods Med Res. 2023 Feb;32(2):229-241. doi: 10.1177/09622802221133555.
5
Umifenovir in hospitalized moderate to severe COVID-19 patients: A randomized clinical trial.乌米芬诺韦治疗住院的中重度新型冠状病毒肺炎患者：一项随机临床试验。
Int Immunopharmacol. 2021 Oct;99:107969. doi: 10.1016/j.intimp.2021.107969. Epub 2021 Jul 10.
6
Cardiac surgeons' concerns, perceptions, and responses during the COVID-19 pandemic.心脏外科医生在 COVID-19 大流行期间的关注、看法和应对措施。
J Card Surg. 2021 Sep;36(9):3040-3051. doi: 10.1111/jocs.15681. Epub 2021 Jun 12.
7
Role of interferon therapy in severe COVID-19: the COVIFERON randomized controlled trial.干扰素治疗在重症 COVID-19 中的作用：COVIFERON 随机对照试验。
Sci Rep. 2021 Apr 13;11(1):8059. doi: 10.1038/s41598-021-86859-y.
8
An ethics framework for consolidating and prioritizing COVID-19 clinical trials.用于整合和优先考虑 COVID-19 临床试验的伦理框架。
Clin Trials. 2021 Apr;18(2):226-233. doi: 10.1177/1740774520988669. Epub 2021 Feb 2.
9
COVID 19: A Cause for Pause in Undergraduate Medical Education and Catalyst for Innovation.COVID-19：暂停本科医学教育的原因及创新的催化剂。
HEC Forum. 2021 Jun;33(1-2):125-142. doi: 10.1007/s10730-020-09433-5. Epub 2021 Jan 22.
10
Utilitarian Principlism as a Framework for Crisis Healthcare Ethics.效用主义原则作为危机医疗保健伦理学的框架。
HEC Forum. 2021 Jun;33(1-2):45-60. doi: 10.1007/s10730-020-09431-7. Epub 2021 Jan 15.
本文引用的文献
1
Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19.羟氯喹治疗 COVID-19 住院患者的观察性研究。
N Engl J Med. 2020 Jun 18;382(25):2411-2418. doi: 10.1056/NEJMoa2012410. Epub 2020 May 7.
Zotero 插件